Zyden Gentec Ltd
Zyden Gentec Limited, incorporated in India, Listed on the Bombay Stock exchange Limited, the company is engaged in manufacturing of Drug intermediates
- Market Cap ₹ 4.83 Cr.
- Current Price ₹ 0.87
- High / Low ₹ /
- Stock P/E 8.47
- Book Value ₹ 2.35
- Dividend Yield 0.00 %
- ROCE -0.99 %
- ROE -2.00 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Stock is trading at 0.37 times its book value
Cons
- The company has delivered a poor sales growth of -42.2% over past five years.
- Company has a low return on equity of -13.9% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 1,077 days.
- Working capital days have increased from 1,061 days to 2,162 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
6.74 | 6.22 | 8.35 | 24.57 | 17.52 | 12.10 | 9.51 | 7.55 | 1.59 | 0.00 | |
6.41 | 5.93 | 7.60 | 24.04 | 16.29 | 10.93 | 12.42 | 8.56 | 2.90 | 0.08 | |
Operating Profit | 0.33 | 0.29 | 0.75 | 0.53 | 1.23 | 1.17 | -2.91 | -1.01 | -1.31 | -0.08 |
OPM % | 4.90% | 4.66% | 8.98% | 2.16% | 7.02% | 9.67% | -30.60% | -13.38% | -82.39% | |
0.46 | 0.05 | -0.09 | -0.05 | 0.09 | 0.02 | 0.10 | 0.94 | 1.32 | 0.68 | |
Interest | 0.03 | 0.10 | 0.11 | 0.24 | 0.47 | 0.90 | 1.24 | 0.40 | 0.03 | 0.03 |
Depreciation | 0.06 | 0.10 | 0.12 | 0.13 | 0.65 | 0.32 | 0.41 | 0.26 | 0.25 | 0.00 |
Profit before tax | 0.70 | 0.14 | 0.43 | 0.11 | 0.20 | -0.03 | -4.46 | -0.73 | -0.27 | 0.57 |
Tax % | 38.57% | 57.14% | 23.26% | 81.82% | 40.00% | 266.67% | -8.07% | 0.00% | 0.00% | |
0.43 | 0.06 | 0.33 | 0.02 | 0.12 | -0.11 | -4.10 | -0.73 | -0.26 | 0.57 | |
EPS in Rs | 0.20 | 0.03 | 0.16 | 0.01 | 0.05 | -0.04 | -0.74 | -0.13 | -0.05 | 0.11 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | -42% |
3 Years: | -49% |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 5800% |
Stock Price CAGR | |
---|---|
10 Years: | -7% |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -9% |
3 Years: | -14% |
Last Year: | -2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Sep 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.22 | 4.22 | 4.22 | 4.77 | 5.07 | 5.07 | 11.11 | 11.11 | 11.11 | 11.11 |
Reserves | 0.23 | 1.09 | 1.42 | 3.35 | 3.51 | 4.01 | 1.96 | 1.52 | 1.25 | 1.93 |
1.61 | 2.38 | 0.71 | 2.99 | 3.93 | 10.05 | 11.25 | 11.87 | 9.84 | 7.56 | |
4.77 | 4.80 | 3.10 | 0.93 | 3.22 | 3.29 | 2.07 | 1.79 | 2.26 | 4.06 | |
Total Liabilities | 10.83 | 12.49 | 9.45 | 12.04 | 15.73 | 22.42 | 26.39 | 26.29 | 24.46 | 24.66 |
2.50 | 3.49 | 3.29 | 4.18 | 3.71 | 8.96 | 8.75 | 8.53 | 8.25 | 8.25 | |
CWIP | 0.00 | 0.00 | 0.13 | 0.00 | 0.62 | 0.08 | 0.08 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
8.33 | 8.99 | 6.03 | 7.86 | 11.40 | 13.38 | 17.56 | 17.75 | 16.20 | 16.40 | |
Total Assets | 10.83 | 12.49 | 9.45 | 12.04 | 15.73 | 22.42 | 26.39 | 26.29 | 24.46 | 24.66 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|---|---|---|---|---|
-1.06 | 0.43 | -1.94 | -2.69 | 3.98 | -1.61 | -1.78 | 3.69 | 0.26 | |
-1.48 | -1.11 | 0.17 | -0.96 | -4.67 | -4.25 | -6.44 | 0.35 | 1.34 | |
2.26 | 0.52 | 1.73 | 3.64 | 0.85 | 5.91 | 8.08 | -4.03 | -1.69 | |
Net Cash Flow | -0.28 | -0.16 | -0.04 | -0.01 | 0.16 | 0.05 | -0.14 | 0.01 | -0.09 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 177.63 | 130.86 | 41.09 | 56.60 | 82.08 | 93.21 | 82.52 | 228.19 | 1,076.64 |
Inventory Days | 157.08 | 272.09 | 195.70 | 60.64 | 73.96 | 257.52 | 93.09 | 70.13 | 122.26 |
Days Payable | 279.25 | 316.33 | 31.56 | 8.23 | 70.42 | 75.24 | 39.37 | 55.22 | 274.64 |
Cash Conversion Cycle | 55.45 | 86.62 | 205.23 | 109.01 | 85.63 | 275.50 | 136.24 | 243.09 | 924.26 |
Working Capital Days | 182.50 | 247.64 | 132.89 | 105.77 | 172.08 | 288.08 | 495.49 | 525.50 | 2,162.45 |
ROCE % | 3.49% | 12.54% | 4.81% | 5.67% | 5.50% | -14.78% | -1.35% | -0.99% |
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 29 Mar 2016
- Financial Results for December 31, 2015 22 Feb 2016
-
Adjournment of Board Meeting
13 Feb 2016 - Due to some unavoidable circumstances the Board have decided to postponed and adjourned the meeting for considerations and Approval of Un - Audited Financial Results …
- Financial Results for Sept 30, 2015 (Clear Copy) 1 Jan 2016
- Outcome of Board Meeting 14 Nov 2015